Pronzato P - Search Results

1

Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC).

Ardizzoni A, Pronzato P, Repetto L, De Palma M, Canobbio L, Gulisano M, Fusco V, Rosso R, Ganzina F. Ardizzoni A, et al. Among authors: pronzato p. Cancer Invest. 1988;6(4):409-11. doi: 10.3109/07357908809080069. Cancer Invest. 1988. PMID: 2846128

2

Oral chemotherapy for poor risk small-cell lung cancer patients with combined idarubicin and etoposide.

Ardizzoni A, Pennucci C, Fusco V, Gulisano M, Bonavia M, Pronzato P, De Palma M, Serrano J, Rosso R. Ardizzoni A, et al. Among authors: pronzato p. Anticancer Res. 1989 Jul-Aug;9(4):937-9. Anticancer Res. 1989. PMID: 2554789

3

Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.

Ardizzoni A, Fusco V, Gulisano M, Pronzato P, Baracco F, Capaccio A, Pastorino G, Nosenzo M, Felletti R, Fabiano F, et al. Ardizzoni A, et al. Among authors: pronzato p. Cancer Treat Rep. 1987 Dec;71(12):1311-2. Cancer Treat Rep. 1987. PMID: 2825994 No abstract available.

4

Phase II trials of idarubicin, a new anthracycline.

Rosso R, Ardizzoni A, Conte P, Fusco V, Gulisano M, Lionetto R, Pronzato P, Repetto L. Rosso R, et al. Among authors: pronzato p. Chemioterapia. 1987 Jun;6(2 Suppl):694. Chemioterapia. 1987. PMID: 2855618 No abstract available.

5

Phase II study of lonidamine in metastatic breast cancer.

Pronzato P, Amoroso D, Bertelli G, Conte PF, Cusimano MP, Ciottoli GB, Gulisano M, Lionetto R, Rosso R. Pronzato P, et al. Br J Cancer. 1989 Feb;59(2):251-3. doi: 10.1038/bjc.1989.51. Br J Cancer. 1989. PMID: 2930690 Free PMC article.

6

Idarubicin: an evaluation of cardiac toxicity in 77 patients with solid tumors.

Bertelli G, Amoroso D, Pronzato P, Rosso R. Bertelli G, et al. Among authors: pronzato p. Anticancer Res. 1988 Jul-Aug;8(4):645-6. Anticancer Res. 1988. PMID: 3178154

7

Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.

Pennucci MC, Ardizzoni A, Pronzato P, Fioretti M, Lanfranco C, Verna A, Giorgi G, Vigani A, Frola C, Rosso R. Pennucci MC, et al. Among authors: pronzato p. Cancer. 1997 May 15;79(10):1897-902. doi: 10.1002/(sici)1097-0142(19970515)79:10<1897::aid-cncr9>3.0.co;2-d. Cancer. 1997. PMID: 9149015 Clinical Trial.

8

Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer.

Repetto L, Miglietta L, Gardin G, Naso C, Giudici S, Merlini L, Queirolo P, Campora E, Pronzato P, Rosso R. Repetto L, et al. Among authors: pronzato p. Ann Oncol. 1992 Feb;3(2):165-6. doi: 10.1093/oxfordjournals.annonc.a058135. Ann Oncol. 1992. PMID: 1606088 Free article.

9

Tamoxifen and alpha interferon in advanced breast cancer.

Miglietta L, Repetto L, Gardin G, Amoroso D, Giudici S, Naso C, Merlini L, Queirolo P, Campora E, Pronzato P, et al. Miglietta L, et al. Among authors: pronzato p. J Chemother. 1991 Dec;3(6):383-6. doi: 10.1080/1120009x.1991.11739125. J Chemother. 1991. PMID: 1819622

10

Intensive chemotherapy with cisplatin, mitoxantrone, methotrexate and vincristine in metastatic breast cancer.

Queirolo P, Repetto L, Gardin G, Miglietta L, Guido T, Pronzato P, Rosso R. Queirolo P, et al. Among authors: pronzato p. J Chemother. 1991 Jun;3(3):194-7. doi: 10.1080/1120009x.1991.11739092. J Chemother. 1991. PMID: 1919659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters